Metabolic genetic polymorphisms and susceptibility to lung cancer

Lung Cancer. 2001 May;32(2):109-12. doi: 10.1016/s0169-5002(00)00215-4.

Abstract

Activity of some enzymes implicated in the metabolism of tobacco carcinogens presents a great variability between individuals due to the existence of a polymorphism in gene coding for these enzymes. Individual susceptibility to develop lung cancer could therefore depend not only on exposure to tobacco smoking, but also on genetic capacity to activate or inactivate tobacco carcinogens. This article summarizes the state of knowledge on metabolic polymorphisms and lung cancer susceptibility, and opens the discussion on the future direction of this promising way of research.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Arylamine N-Acetyltransferase / genetics
  • Arylamine N-Acetyltransferase / metabolism
  • Biotransformation / genetics
  • Carcinogens / pharmacokinetics*
  • Cytochrome P-450 Enzyme System / genetics*
  • Cytochrome P-450 Enzyme System / metabolism
  • Genetic Predisposition to Disease
  • Glutathione Transferase / genetics
  • Glutathione Transferase / metabolism
  • Heterocyclic Compounds / pharmacokinetics
  • Humans
  • Inactivation, Metabolic / genetics
  • Isoenzymes / genetics*
  • Isoenzymes / metabolism
  • Lung Neoplasms / enzymology
  • Lung Neoplasms / etiology
  • Lung Neoplasms / genetics*
  • Microsomes / enzymology
  • Nicotiana
  • Plants, Toxic
  • Polycyclic Aromatic Hydrocarbons / pharmacokinetics
  • Polymorphism, Genetic*
  • Smoking / adverse effects

Substances

  • Carcinogens
  • Heterocyclic Compounds
  • Isoenzymes
  • Polycyclic Aromatic Hydrocarbons
  • Cytochrome P-450 Enzyme System
  • Arylamine N-Acetyltransferase
  • Glutathione Transferase